TENON MEDICAL INC (TNON) Fundamental Analysis & Valuation

NASDAQ:TNON • US88066N3035

0.766 USD
-0.01 (-0.85%)
Last: Mar 5, 2026, 03:10 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This TNON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

TNON gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. The financial health of TNON is average, but there are quite some concerns on its profitability. TNON is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. TNON Profitability Analysis

1.1 Basic Checks

  • TNON had negative earnings in the past year.
  • In the past year TNON has reported a negative cash flow from operations.
  • TNON had negative earnings in each of the past 5 years.
  • In the past 5 years TNON always reported negative operating cash flow.
TNON Yearly Net Income VS EBIT VS OCF VS FCFTNON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • TNON's Return On Assets of -123.59% is on the low side compared to the rest of the industry. TNON is outperformed by 83.70% of its industry peers.
  • The Return On Equity of TNON (-267.01%) is worse than 76.63% of its industry peers.
Industry RankSector Rank
ROA -123.59%
ROE -267.01%
ROIC N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNON Yearly ROA, ROE, ROICTNON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • TNON has a Gross Margin of 52.40%. This is comparable to the rest of the industry: TNON outperforms 48.91% of its industry peers.
  • In the last couple of years the Gross Margin of TNON has declined.
  • The Profit Margin and Operating Margin are not available for TNON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
TNON Yearly Profit, Operating, Gross MarginsTNON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TNON Health Analysis

2.1 Basic Checks

  • TNON does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TNON has been increased compared to 1 year ago.
  • Compared to 5 years ago, TNON has more shares outstanding
  • There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TNON Yearly Shares OutstandingTNON Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNON Yearly Total Debt VS Total AssetsTNON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -13.15, we must say that TNON is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -13.15, TNON is doing worse than 80.98% of the companies in the same industry.
  • There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.15
ROIC/WACCN/A
WACC9.92%
TNON Yearly LT Debt VS Equity VS FCFTNON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • TNON has a Current Ratio of 2.15. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.15, TNON is in line with its industry, outperforming 43.48% of the companies in the same industry.
  • TNON has a Quick Ratio of 1.70. This is a normal value and indicates that TNON is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.70, TNON perfoms like the industry average, outperforming 45.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.7
TNON Yearly Current Assets VS Current LiabilitesTNON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. TNON Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.17% over the past year.
  • The Revenue has decreased by -2.47% in the past year.
  • The Revenue has been growing by 130.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)84.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.98%
Revenue 1Y (TTM)-2.47%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%32.24%

3.2 Future

  • TNON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.82% yearly.
  • Based on estimates for the next years, TNON will show a very strong growth in Revenue. The Revenue will grow by 53.87% on average per year.
EPS Next Y92.39%
EPS Next 2Y39.97%
EPS Next 3Y25.34%
EPS Next 5Y14.82%
Revenue Next Year3.71%
Revenue Next 2Y33.19%
Revenue Next 3Y38.06%
Revenue Next 5Y53.87%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

Find the best growth stocksShow best growing peers

1

4. TNON Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TNON. In the last year negative earnings were reported.
  • Also next year TNON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNON Price Earnings VS Forward Price EarningsTNON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNON Per share dataTNON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TNON's earnings are expected to grow with 25.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.97%
EPS Next 3Y25.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TNON Dividend Analysis

5.1 Amount

  • TNON does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TNON Fundamentals: All Metrics, Ratios and Statistics

TENON MEDICAL INC

NASDAQ:TNON (3/5/2026, 3:10:51 PM)

0.766

-0.01 (-0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-19
Inst Owners2.45%
Inst Owner Change63.01%
Ins Owners4.06%
Ins Owner Change12.02%
Market Cap8.29M
Revenue(TTM)3.23M
Net Income(TTM)-12.81M
Analysts82.5
Price Target2.81 (266.84%)
Short Float %9.24%
Short Ratio0.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.46%
Min EPS beat(2)-5.99%
Max EPS beat(2)24.91%
EPS beat(4)3
Avg EPS beat(4)7.92%
Min EPS beat(4)-5.99%
Max EPS beat(4)24.91%
EPS beat(8)7
Avg EPS beat(8)14.46%
EPS beat(12)10
Avg EPS beat(12)13.96%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-18.33%
Min Revenue beat(2)-39.2%
Max Revenue beat(2)2.53%
Revenue beat(4)1
Avg Revenue beat(4)-31.32%
Min Revenue beat(4)-47.97%
Max Revenue beat(4)2.53%
Revenue beat(8)1
Avg Revenue beat(8)-23.82%
Revenue beat(12)1
Avg Revenue beat(12)-19.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.56
P/FCF N/A
P/OCF N/A
P/B 1.73
P/tB 4.38
EV/EBITDA N/A
EPS(TTM)-4.31
EYN/A
EPS(NY)-0.99
Fwd EYN/A
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0.3
BVpS0.44
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -123.59%
ROE -267.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.4%
FCFM N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.49%
Cap/Sales 1.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.7
Altman-Z -13.15
F-Score3
WACC9.92%
ROIC/WACCN/A
Cap/Depr(3y)429.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.98%
EPS Next Y92.39%
EPS Next 2Y39.97%
EPS Next 3Y25.34%
EPS Next 5Y14.82%
Revenue 1Y (TTM)-2.47%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%32.24%
Revenue Next Year3.71%
Revenue Next 2Y33.19%
Revenue Next 3Y38.06%
Revenue Next 5Y53.87%
EBIT growth 1Y4.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.01%
OCF growth 3YN/A
OCF growth 5YN/A

TENON MEDICAL INC / TNON FAQ

What is the fundamental rating for TNON stock?

ChartMill assigns a fundamental rating of 3 / 10 to TNON.


Can you provide the valuation status for TENON MEDICAL INC?

ChartMill assigns a valuation rating of 1 / 10 to TENON MEDICAL INC (TNON). This can be considered as Overvalued.


Can you provide the profitability details for TENON MEDICAL INC?

TENON MEDICAL INC (TNON) has a profitability rating of 0 / 10.


How financially healthy is TENON MEDICAL INC?

The financial health rating of TENON MEDICAL INC (TNON) is 5 / 10.